Dirk Schapeler is Vice President Digital Health US at Bayer. He previously served as Head of Bayer's LifeScience iHUB innovation center that he founded in Silicon Valley in 2015. An engineer in electronics and mechanics he studied in Karlsruhe Germany. Dirk previously served as the CEO of Bayer's ViviTouch subsidiary Artificial Muscle Inc. in Sunnyvale. He is a co-inventor of electro active polymers and owns more than 13 patents. He has been working in Automotive, Material Science and Healthcare for almost 2 decades in the US, Germany, France and Mexico. In his current role he focuses on the digitalization of the pharma, consumer care and crop science industry.
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2017, the Group employed around 99,800 people and had sales of EUR 35.0 billion. Capital expenditures amounted to EUR 2.4 billion, R&D expenses to EUR 4.5 billion. For more information, go to www.bayer.com